Voodoo Scientific Leverages Ginkgo Enzyme Services to Develop Enzymatic Processing Aid to Eliminate the Harsh "Bite" from Distilled Alcoholic Beverages
Voodoo Scientific and Ginkgo Bioworks (NYSE: DNA) have announced a collaboration to develop an enzymatic solution for eliminating the harsh "bite" in distilled alcoholic beverages. Voodoo will leverage Ginkgo's Enzyme Services to optimize an enzyme that can be used in spirits manufacturing, from craft to global-scale production.
The enzymatic solution targets specific compounds responsible for alcohol harshness without affecting other flavor components. It can be added as a processing aid during fermentation, requiring no changes to existing production processes. This innovation aims to enable distillers to produce ultra-premium, smoother spirits and develop new flavor profiles across various spirit types.
Voodoo's solution was recently recognized as a top innovation at the Distilled Spirits Council of the United States' (DISCUS) annual conference. The collaboration combines Voodoo's industry-specific knowledge with Ginkgo's protein discovery and design capabilities.
Voodoo Scientific e Ginkgo Bioworks (NYSE: DNA) hanno annunciato una collaborazione per sviluppare una soluzione enzimatica per eliminare il forte "morso" nelle bevande alcoliche distillate. Voodoo sfrutterà i Servizi Enzimatici di Ginkgo per ottimizzare un enzima che può essere utilizzato nella produzione di alcolici, dalla produzione artigianale a quella su scala globale.
La soluzione enzimatica si concentra su composti specifici responsabili dell'asprezza dell'alcol senza influenzare altri componenti aromatici. Può essere aggiunta come ausilio al processo durante la fermentazione, senza richiedere modifiche ai processi produttivi esistenti. Questa innovazione mira a consentire ai distillatori di produrre spiriti ultra-premium, più lisci e sviluppare nuovi profili aromatici in vari tipi di alcolici.
La soluzione di Voodoo è stata recentemente riconosciuta come una delle migliori innovazioni durante la conferenza annuale del Distilled Spirits Council degli Stati Uniti (DISCUS). La collaborazione combina le conoscenze specifiche del settore di Voodoo con le capacità di scoperta e progettazione delle proteine di Ginkgo.
Voodoo Scientific y Ginkgo Bioworks (NYSE: DNA) han anunciado una colaboración para desarrollar una solución enzimática para eliminar el fuerte "picor" en las bebidas alcohólicas destiladas. Voodoo aprovechará los Servicios Enzimáticos de Ginkgo para optimizar una enzima que se puede utilizar en la fabricación de licores, desde la producción artesanal hasta la producción a gran escala.
La solución enzimática se centra en compuestos específicos responsables de la dureza del alcohol sin afectar a otros componentes de sabor. Se puede añadir como auxiliar de procesamiento durante la fermentación, sin requerir cambios en los procesos de producción existentes. Esta innovación tiene como objetivo permitir a los destiladores producir espirituosos ultra-premium, más suaves y desarrollar nuevos perfiles de sabor en varios tipos de licores.
La solución de Voodoo fue reconocida recientemente como una de las mejores innovaciones en la conferencia anual del Distilled Spirits Council de los Estados Unidos (DISCUS). La colaboración combina el conocimiento específico de la industria de Voodoo con las capacidades de descubrimiento y diseño de proteínas de Ginkgo.
부두 사이언티픽과 진코 바이오웍스(NYSE: DNA)가 증류주에서 강한 "맛"을 없애기 위한 효소 솔루션 개발을 위한 협업을 발표했습니다. 부두는 진코의 효소 서비스를 이용해 다양한 규모의 증류주 생산에 사용할 수 있는 효소 최적화를 진행할 예정입니다.
효소 솔루션은 다른 향미 성분에 영향을 주지 않으면서 알코올의 강함을 유발하는 특정 화합물을 타겟으로 합니다. 기존 생산 과정에 변경 없이 발효 과정에서의 처리 보조제로 추가할 수 있습니다. 이 혁신은 증류업자들이 울트라 프리미엄, 더 부드러운 주류를 생산하고 다양한 주류 유형에서 새로운 풍미 프로파일을 개발할 수 있게 하려는 목표를 가지고 있습니다.
부두의 솔루션은 최근 미국 증류주 협회(DISCUS)의 연례 회의에서 최고의 혁신으로 인정받았습니다. 이번 협업은 부두의 산업별 지식과 진코의 단백질 발견 및 설계 능력을 결합합니다.
Voodoo Scientific et Ginkgo Bioworks (NYSE : DNA) ont annoncé une collaboration pour développer une solution enzymatique visant à éliminer le fort "goût" dans les boissons alcoolisées distillées. Voodoo s'appuiera sur les Services Enzymatiques de Ginkgo pour optimiser une enzyme pouvant être utilisée dans la production d'alcools, allant de la production artisanale à celle à l'échelle mondiale.
La solution enzymatique cible des composés spécifiques responsables de l'âpreté de l'alcool sans affecter d'autres composants de saveur. Elle peut être ajoutée comme aide au traitement lors de la fermentation, sans nécessiter de modifications des processus de production existants. Cette innovation vise à permettre aux distillateurs de produire des alcools ultra-premium, plus doux et de développer de nouveaux profils de saveurs dans différents types de spiritueux.
La solution de Voodoo a récemment été reconnue comme l'une des meilleures innovations lors de la conférence annuelle du Distilled Spirits Council des États-Unis (DISCUS). Cette collaboration combine l'expertise sectorielle de Voodoo avec les capacités de découverte et de conception de protéines de Ginkgo.
Voodoo Scientific und Ginkgo Bioworks (NYSE: DNA) haben eine Zusammenarbeit bekannt gegeben, um eine enzymatische Lösung zur Beseitigung des starken "Bisses" in destillierten alkoholischen Getränken zu entwickeln. Voodoo wird die Enzymdienste von Ginkgo nutzen, um ein Enzym zu optimieren, das in der Spirituosenproduktion verwendet werden kann, von der handwerklichen bis zur globalen Produktion.
Die enzymatische Lösung zielt auf spezifische Verbindungen ab, die für die Schärfe des Alkohols verantwortlich sind, ohne andere Geschmacksbestandteile zu beeinflussen. Sie kann als Verarbeitungshelfer während der Fermentation hinzugefügt werden, ohne dass Änderungen an den bestehenden Produktionsprozessen erforderlich sind. Diese Innovation soll es Destillateuren ermöglichen, ultra-premium, weichere Spirituosen herzustellen und neue Geschmacksprofile in verschiedenen Spirituosenarten zu entwickeln.
Die Lösung von Voodoo wurde kürzlich als eine der besten Innovationen auf der Jahrestagung des Distilled Spirits Council der Vereinigten Staaten (DISCUS) anerkannt. Die Zusammenarbeit kombiniert das branchenspezifische Wissen von Voodoo mit den Fähigkeiten von Ginkgo in der Proteinentdeckung und -gestaltung.
- Potential for creating ultra-premium spirit products with smoother taste
- No changes required to existing production processes for implementation
- Recognition as a top innovation at DISCUS annual conference
- Enables development of new flavor profiles across various spirit types
- None.
Most distilled alcoholic beverages produce some degree of harsh sensation, or "bite," when consumed, which is a major deterrent for many potential customers. No mellowing technique used by distillers to date has been able to fully eliminate this unpleasant attribute. Voodoo Scientific identified the scientific cause for this harshness and created their enzymatic solution to give distillers the ability to manage it. Distillers can use this novel enzymatic solution to produce more premium products by creating smooth spirits. Voodoo's ability to make smoother spirits also enables the development of new flavor profiles across the full range of spirits types (e.g., vodkas, whiskies, etc.).
The Voodoo enzymatic solution targets and eliminates only the specific compounds that are responsible for the harshness of alcohol, while not affecting other components of the beverage's flavor profile. Voodoo's enzymatic solution also does not require spirits producers to change their existing processes or equipment as it is added as a processing aid during fermentation so it does not persist into the bottle. Voodoo Scientific's enzymatic solution was recently recognized as a top innovation in the spirits industry at the Distilled Spirits Council of
"Providing distillers with a means to eliminate, or control, the harshness of their spirits products is very gratifying." said Joana Montenegro, co-founder and Chief Science Officer at Voodoo. "We believe we can enable new innovation in this large global industry and in ways that are truly meaningful to consumers seeking premium experiences. Ginkgo was the best choice of partners for us among the ones we considered because of their unique combination of strong scientific capabilities and a business model that fits an early-stage company like ours."
"Engineering this class of enzyme to operate under the unique conditions required for distilled alcoholic beverages is a great application for Ginkgo Enzyme Services." said Jennifer Wipf, SVP, Head of Commercial Cell Engineering at Ginkgo. "Improving the functionality of enzymes underpinning critical production processes - making enzymes work better - is an area we're passionate about because it opens up real business opportunities for our customers, especially as they push into new product development."
To learn more about Ginkgo's work in this space, join us on June 30th from 10:00 - 11:00 am ET for our Functional Food Proteins with Microbial Expression Systems virtual event.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo's biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgo and @ConcentricByGBW), Instagram (@GinkgoBioworks and @ConcentricByGinkgo), or LinkedIn.
About Voodoo Scientific
Voodoo Scientific is a company innovating in food technology to create better consumer experiences. Voodoo identified the precise cause of the unpleasant painful harshness in spirits, and has developed a product that enables distillers the ability to fully eliminate this harshness to create truly smooth spirits. Voodoo Scientific's product has been recognized by the leading spirits association, DISCUS, as among the top innovations in the industry. For more information, visit VoodooScientific.com
Forward-Looking Statements of Ginkgo Bioworks
This press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the capabilities and potential success of the partnership and Ginkgo's cell programming platform. These forward-looking statements generally are identified by the words "believe," "can," "project," "potential," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: (i) volatility in the price of Ginkgo's securities due to a variety of factors, including changes in the competitive and highly regulated industries in which Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo's business, (ii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, (iii) the risk of downturns in demand for products using synthetic biology, (iv) the unpredictability of the duration of the COVID-19 pandemic and the demand for COVID-19 testing and the commercial viability of our COVID-19 testing business, (v) changes to the biosecurity industry, including due to advancements in technology, emerging competition and evolution in industry demands, standards and regulations, (vi) our ability to realize the expected benefits of merger and acquisition transactions, (vii) the outcome of any legal proceedings against Ginkgo, including as a result of recent acquisitions, (viii) our ability to realize the expected benefits from and the success of our Foundry platform programs, (ix) our ability to successfully develop engineered cells, bioprocesses, data packages or other deliverables, and (x) the product development or commercialization success of our customers. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of Ginkgo's quarterly report on Form 10-Q filed with the
VOODOO SCIENTIFIC CONTACT:
joana@voodooscientific.com
GINKGO BIOWORKS INVESTOR CONTACT:
investors@ginkgobioworks.com
GINKGO BIOWORKS MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/voodoo-scientific-leverages-ginkgo-enzyme-services-to-develop-enzymatic-processing-aid-to-eliminate-the-harsh-bite-from-distilled-alcoholic-beverages-301865080.html
SOURCE Ginkgo Bioworks
FAQ
What is the purpose of Voodoo Scientific's collaboration with Ginkgo Bioworks (DNA)?
How does Voodoo Scientific's enzymatic solution work in spirit production?
Will distillers need to change their existing processes to use Voodoo's enzymatic solution?
What recognition has Voodoo Scientific's enzymatic solution received in the spirits industry?
